O
WAT icon

OrbiMed’s Waters Corp WAT Stock Holding History

OrbiMed’s Portfolio WAT Stock Details WAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Buy
+40,300
New +$13.7M 0.28% 76

Other funds holding WAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OrbiMed's WAT Position: Q2 2026 in Review

OrbiMed opened a new position in Waters Corp (WAT) in Q2 2026: 40,300 shares worth $15.1M. The stake represents 0.28% of the portfolio and ranks #76 among its holdings.

1,177 funds tracked by Wall St. Rank hold WAT as of Q2 2026.

  • OrbiMed held 40,300 shares of Waters Corp worth $15.1M as of Q2 2026.
  • Waters Corp was a new OrbiMed position in Q2 2026.
  • Waters Corp made up 0.28% of OrbiMed's portfolio in Q2 2026, its #76 holding.
  • 1,177 funds tracked by Wall St. Rank held Waters Corp as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.